(2026). Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement. Application of Clinical Genetics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement."
Application of Clinical Genetics 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement."
Application of Clinical Genetics, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.